Island Pharmaceuticals Limited (ASX: ILA)

Sector: Health Care

Market cap: A$86M (as of 2 Nov 2026)

Island is a drug development and repurposing company, focused on repurposing and clinical development solutions for viral diseases with no existing therapies.

Data as of 2 Nov 2026.

Recent capital raises

Date	Type	Amount	Price	Discount	Source
4 Feb 2026	Placement	$9M	$0.35	10% discount	Filing ↗
21 May 2025	Placement	$3.6M	$0.15	16.67% discount	Filing ↗
2 Oct 2024	Placement	$3.5M	$0.07	12.5% discount	Filing ↗
18 Mar 2024	Rights issue	$1.95M	$0.06	—	Filing ↗
9 Apr 2021	Public offer	$7.5M	$0.25	—	Filing ↗

Substantial holders — latest moves

Date	Holder	Move	Holding	Source
9 Dec 2025	DR WILLIAM JAMES GARNER	Decrease	16.860% → 15.500%	Filing ↗
9 Dec 2025	DANIEL TILLETT	Increase	5.550% → 7.800%	Filing ↗
9 Dec 2025	MR JASON ALAN CARROLL	Decrease	13.260% → 11.920%	Filing ↗
29 Aug 2025	DR WILLIAM JAMES GARNER	Entry	?% → 16.86%	Filing ↗
29 Aug 2025	DR WILLIAM JAMES GARNER	Entry	?% → 16.86%	Filing ↗

Director trades — on-market

Date	Director	Trade	Source
24 July 2025	Jason Alan Carroll	Bought 124,250	Filing ↗
3 Aug 2022	DR DAVID FOSTER	Bought 31,303	Filing ↗
21 June 2022	DR DAVID FOSTER	Bought 40,000	Filing ↗

Cash and runway

Metric	Value	As of	Source
Cash	A$8M	30 Sept 2026	Filing ↗
Runway	1.6 quarters	30 Sept 2026	Filing ↗

Ask about ILA in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

Has ILA raised money in the last year, and at what discount?
What was ILA's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading ILA…